Global challenges Study Guide

The global human population continues to grow, which places increasing demands on our food supply. To meet these demands, agricultural practices must adapt and become more efficient. Key challenges include limited arable land, climate change impacts, and the need for sustainable practices. Several agricultural solutions are being explored and implemented to address these challenges. These include increasing the efficiency of food production through methods like hydroponics and aeroponics, which involve growing plants without soil in nutrient-rich water environments, often in controlled indoor settings. This allows for higher yields, reduced water usage, and protection from pests and adverse weather. Additionally, developing new crop varieties through selective breeding or genetic modification can lead to crops with higher yields, better nutritional content, or increased resistance to pests and diseases. Reducing food waste throughout the supply chain, from farm to fork, is also crucial. This involves improving harvesting, storage, processing, and distribution methods, as well as encouraging consumers to waste less food. Using fertilisers and pesticides responsibly can boost crop yields, but their overuse can lead to environmental issues. Therefore, integrated pest management and precision agriculture are valuable approaches to minimise their environmental impact while maximising productivity. Finally, developing alternative food sources, such as insects or lab-grown meat, could diversify our diet and reduce the environmental footprint associated with traditional livestock farming. Implementing these solutions requires a balance between increasing food production and ensuring environmental sustainability.

The process of discovering and developing new medicines is complex, lengthy, and involves multiple stages to ensure both effectiveness and safety. It typically begins with identifying a target, such as a specific protein or pathogen, that plays a role in a disease. Researchers then screen vast libraries of chemical compounds or natural products to find "lead compounds" that interact with this target. Once potential candidates are found, they undergo rigorous pre-clinical testing, which involves laboratory and animal studies, to assess their safety, dosage, and initial efficacy. This stage is crucial for identifying any serious toxic effects or negative reactions before human trials. If a compound passes pre-clinical tests, it moves into clinical trials, which are conducted in three phases with human volunteers. Phase 1 involves a small group of healthy volunteers to evaluate safety, determine safe dosage ranges, and identify side effects. Phase 2 extends to a larger group of patients with the target condition to assess effectiveness and further evaluate safety. Phase 3 compares the new medicine to existing treatments or a placebo in an even larger and more diverse patient population to confirm effectiveness, monitor side effects, and gather information for safe use. Only after a medicine successfully completes all three phases of clinical trials and demonstrates both efficacy and an acceptable safety profile can it be submitted for regulatory approval. Even after approval, medicines are continuously monitored in Phase 4 for long-term effects and rare side effects that might not have been detected in earlier, smaller trials.